ICER is requisite for Th17 differentiation

Nature Communications

Volumn 7, Issue , 2016, Pages

  Yoshida, Nobuya ^a   Comte, Denis ^a,b   Mizui, Masayuki ^a   Otomo, Kotaro ^a   Rosetti, Florencia ^a   Mayadas, Tanya N ^a   Crispín, José C ^a   Bradley, Sean J ^a   Koga, Tomohiro ^a   Kono, Michihito ^a   Karampetsou, Maria P ^a   Kyttaris, Vasileios C ^a   Tenbrock, Klaus ^c   Tsokos, George C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INDUCIBLE CAMP EARLY REPRESSOR; INTERLEUKIN 17; INTERLEUKIN 6; REPRESSOR PROTEIN; RETINOID RELATED ORPHAN RECEPTOR GAMMA; STAT3 PROTEIN; UNCLASSIFIED DRUG;

CELLS AND CELL COMPONENTS; DIFFERENTIATION; DISEASE INCIDENCE; GENE EXPRESSION; IMMUNITY; PROTEIN; THORIUM ISOTOPE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; ENCEPHALOMYELITIS; GLOMERULONEPHRITIS; HUMAN; IN VITRO STUDY; INFLAMMATORY DISEASE; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; SYSTEMIC LUPUS ERYTHEMATOSUS; TH17 CELL;

MUS;

EID: 84989271289     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms12993     Document Type: Article

References (39)

1. Crispin, J. C., Tsokos, G. C. Interleukin-17-producing T cells in lupus. Curr. Opin. Rheumatol. 22, 499-503 (2010).
2. Ciofani, M. et al. A validated regulatory network for Th17 cell specification. Cell 151, 289-303 (2012).
3. Harrington, L. E. et al. Interleukin 17-producing CD4\+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6, 1123-1132 (2005).
4. Korn, T., Bettelli, E., Oukka, M., Kuchroo, V. K. IL-17 and Th17 Cells. Annu. Rev. Immunol. 27, 485-517 (2009).
5. Tsokos, G. C. Systemic lupus erythematosus. N. Engl. J. Med. 365, 2110-2121 (2011).
6. Rauen, T., Hedrich, C. M., Juang, Y. T., Tenbrock, K., Tsokos, G. C. cAMPresponsive element modulator (CREM)alpha protein induces interleukin 17A expression and mediates epigenetic alterations at the interleukin-17A gene locus in patients with systemic lupus erythematosus. J. Biol. Chem. 286, 43437-43446 (2011).
7. Lippe, R. et al. CREMalpha overexpression decreases IL-2 production, induces a T(H)17 phenotype and accelerates autoimmunity. J. Mol. Cell Biol. 4, 121-123 (2012).
8. Foulkes, N. S., Sassone-Corsi, P. More is better: activators and repressors from the same gene. Cell 68, 411-414 (1992).
9. Foulkes, N. S., Borrelli, E., Sassone-Corsi, P. CREM gene: use of alternative DNA-binding domains generates multiple antagonists of cAMP-induced transcription. Cell 64, 739-749 (1991).
10. Bodor, J., Spetz, A. L., Strominger, J. L., Habener, J. F. cAMP inducibility of transcriptional repressor ICER in developing and mature human T lymphocytes. Proc. Natl Acad. Sci. USA 93, 3536-3541 (1996).
11. Bodor, J. et al. Suppression of T-cell responsiveness by inducible cAMP early repressor (ICER). J. Leukoc. Biol. 69, 1053-1059 (2001).
12. Verjans, E. et al. The cAMP response element modulator (CREM) regulates TH2 mediated inflammation. Oncotarget 6, 38538-38551 (2015).
13. Crispin, J. C. et al. Cutting edge: protein phosphatase 2A confers susceptibility to autoimmune disease through an IL-17-dependent mechanism. J. Immunol. 188, 3567-3571 (2012).
14. Koga, T. et al. CaMK4-dependent activation of AKT/mTOR and CREM-alpha underlies autoimmunity-associated Th17 imbalance. J. Clin. Invest. 124, 2234-2245 (2014).
15. Pisitkun, P. et al. Interleukin-17 cytokines are critical in development of fatal lupus glomerulonephritis. Immunity 37, 1104-1115 (2012).
16. Ohl, K., Wiener, A., Schippers, A., Wagner, N., Tenbrock, K. Interleukin-2 treatment reverses effects of cAMP-responsive element modulator alpha-overexpressing T cells in autoimmune-prone mice. Clin. Exp. Immunol. 181, 76-86 (2015).
17. Mosenden, R., Tasken, K. Cyclic AMP-mediated immune regulation-overview of mechanisms of action in T cells. Cell. Signal. 23, 1009-1016 (2011).
18. Hernandez, J. B. et al. The CREB/CRTC2 pathway modulates autoimmune disease by promoting Th17 differentiation. Nat. Commun. 6, 7216 (2015).
19. Kim, H. P., Leonard, W. J. CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation. J. Exp. Med. 204, 1543-1551 (2007).
20. Ogawa, C. et al. TGF-beta-mediated Foxp3 gene expression is cooperatively regulated by Stat5, Creb, and AP-1 through CNS2. J. Immunol. 192, 475-483 (2014).
21. McGeachy, M. J. et al. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat. Immunol. 8, 1390-1397 (2007).
22. Ooi, J. D., Kitching, A. R., Holdsworth, S. R. Review: T helper 17 cells: their role in glomerulonephritis. Nephrology (Carlton) 15, 513-521 (2010).
23. Park, H. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133-1141 (2005).
24. Kim, J., Krueger, J. G. The immunopathogenesis of psoriasis. Dermatol. Clin. 33, 13-23 (2015).
25. Moulton, V. R., Tsokos, G. C. T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity. J. Clin. Invest. 125, 2220-2227 (2015).
26. Amarilyo, G., Lourenco, E. V., Shi, F. D., La Cava, A. IL-17 promotes murine lupus. J. Immunol. 193, 540-543 (2014).
27. Apostolidis, S. A., Lieberman, L. A., Kis-Toth, K., Crispin, J. C., Tsokos, G. C. The dysregulation of cytokine networks in systemic lupus erythematosus. J. Interferon Cytokine Res. 31, 769-779 (2011).
28. Kyttaris, V. C., Zhang, Z., Kuchroo, V. K., Oukka, M., Tsokos, G. C. Cutting edge: IL-23 receptor deficiency prevents the development of lupus nephritis in C57BL/6-lpr/lpr mice. J. Immunol. 184, 4605-4609 (2010).
29. Crispin, J. C. et al. Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J. Immunol. 181, 8761-8766 (2008).
30. Abdel Galil, S. M., Ezzeldin, N., El-Boshy, M. E. The role of serum IL-17 and IL-6 as biomarkers of disease activity and predictors of remission in patients with lupus nephritis. Cytokine 76, 280-287 (2015).
31. Harada, T. et al. Increased expression of STAT3 in SLE T cells contributes to enhanced chemokine-mediated cell migration. Autoimmunity 40, 1-8 (2007).
32. Vang, A. G. et al. Regulatory T-cells and cAMP suppress effector T-cells independently of PKA-CREM/ICER: a potential role for Epac. Biochem. J. 456, 463-473 (2013).
33. Hochberg, M. C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 40, 1725 (1997).
34. Bombardier, C., Gladman, D. D., Urowitz, M. B., Caron, D., Chang, C. H. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 35, 630-640 (1992).
35. Sunahori, K., Juang, Y. T., Tsokos, G. C. Methylation status of CpG islands flanking a cAMP response element motif on the protein phosphatase 2Ac alpha promoter determines CREB binding and activity. J. Immunol. 182, 1500-1508 (2009).
36. Blendy, J. A., Kaestner, K. H., Weinbauer, G. F., Nieschlag, E., Schutz, G. Severe impairment of spermatogenesis in mice lacking the CREM gene. Nature 380, 162-165 (1996).
37. Nguyen, H. X., Beck, K. D.,erson, A. J. Quantitative assessment of immune cells in the injured spinal cord tissue by flow cytometry: a novel use for a cell purification method. J. Vis. Exp. 50, e2698 (2011).
38. Han, W. et al. [Reduced locomotor sensitization induced by methamphetamine and altered gene expression in ICER overexpressing mice]. Nihon Shinkei Seishin Yakurigaku Zasshi 31, 79-80 (2011).
39. Zhang, F., Meng, G., Strober, W. Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T cells. Nat. Immunol. 9, 1297-1306 (2008).